Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
Recruiting
Observational Study
Non Muscle Invasive Bladder Cancer
Non-Muscle Invasive Bladder Neoplasms
Non-Muscle Invasive Bladder Urothelial Carcinoma
Bladder Cancer
Bladder Disease
Bladder Neoplasm
Bladder Urothelial Carcinoma
Bladder Cancer Stage I, With Cancer in Situ
Bladder Cancer Recurrent
Bladder Urothelial Carcinoma in Situ
Bladder Urothelial Dysplasia
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 20,000 (estimated)
- Sponsor
- IRCCS San Raffaele · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
A database has been created and will be used in which data will be collected in electronic format relating to adult patients who underwent one of the following endoscopic resection surgeries: TURBK, MAPPING, TURBK SECOND LOOK, BLADDER BIOPSIES.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* 18 years or older
* Patients with non-muscle invasive bladder cancer
* Indication to cancer removal through endoscopic resection surgery
* Ability to read and sign the informed consent
Exclusion Criteria:
* Age \<18 years
* Inability to read and sign the informed consent
Contacts